Patients press the hand held device to their neck, which then sends a mild electrical stimulation to the vagus nerve through the skin to reduce pain associated with cluster headaches.
ElectroCore expects the device to be available in the U.S. later this year.
More articles on supply chain:
Global pharmerging market to reach $1.4B by 2025
Price hikes likely added $8.7B to pharma’s net income for 2016, report finds
ASCO: Strategies to control drug costs hinder cancer patient care
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.